Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary

NCT03206177 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Carcinosarcoma, Ovarian

Interventions

DRUG: Galunisertib
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

University of Oklahoma

Collaborators

[object Object]